Muscle ultrasound from diagnostic tool to outcome measure-Quantification is the challenge

Muscle and Nerve

Volumn 52, Issue 3, 2015, Pages 319-320

  Pillen, Sigrid ^a   Van Alfen, Nens ^b  

^a Department of Sleep Medicine Kempenhaeghe Expertise Center for Epileptology Sleep Medicine and Neurocognition   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; AMYOTROPHIC LATERAL SCLEROSIS; COMPUTER PROGRAM; DETERIORATION; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; ECHOGRAPHY; EDITORIAL; ELECTROMYOGRAPHY; FASCICULATION; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MUSCLE DISEASE; MUSCLE ECHOGRAPHY; MUSCLE TISSUE; NEEDLE BIOPSY; NEUROMUSCULAR DISEASE; OUTCOME ASSESSMENT; PHANTOM; POINT OF CARE TESTING; PRIORITY JOURNAL; REFERENCE VALUE; SKELETAL MUSCLE;

HUMANS; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84938990941     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24613     Document Type: Editorial

References (12)

1. Pillen S, Arts IM, Zwarts MJ. Muscle ultrasound in neuromuscular disorders. Muscle Nerve 2008;37:679-693.
2. Misawa S, Noto Y, Shibuya K, Isose S, Sekiguchi Y, Nasu S, et al. Ultrasonographic detection of fasciculations markedly increases diagnostic sensitivity of ALS. Neurology 2011;77:1532-1537.
3. Zaidman CM, Malkus EC, Connolly AM. Muscle ultrasound quantifies disease progression overtime in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve 2015;5X:000-000.
4. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken) 2011;63(suppl 11):S118-S157.
5. Mazzone E, Vasco G, Sormani MP, Torrente Y, Berardinelli A, Messina S, et al. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology 2011;77:250-256.
6. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, et al. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103.
7. Brandsma R, Verbeek RJ, Maurits NM, et al. Visual screening of muscle ultrasound images in children. Ultrasound Med Biol 2014;40:2345-2351.
8. Arts IM, Pillen S, Schelhaas HJ, Overeem S, Zwarts MJ. Normal values for quantitative muscle ultrasonography in adults. Muscle Nerve 2010;41:32-41.
9. Mayans D, Cartwright MS, Walker FO. Neuromuscular ultrasonography: quantifying muscle and nerve measurements. Phys Med Rehabil Clin N Am 2012;23:133-148.
10. Zaidman CM, Wu JS, Wilder S, Darras BT, Rutkove SB. Minimal training is required to reliably perform quantitative ultrasound of muscle. Muscle Nerve 2014;50:124-128.
11. Zaidman CM, Holland MR, Anderson CC, Pestronk A. Calibrated quantitative ultrasound imaging of skeletal muscle using backscatter analysis. Muscle Nerve 2008;38:893-898.
12. Jansen M, van Alfen N, Nijhuis van der Sanden MW, van Dijk JP, Pillen S, de Groot IJ. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy. Neuromuscul Disord 2012;22:306-317.